NCT06207903 · NOT YET RECRUITING

Navigating the Clinical Research Process for Mild Cognitive Impairment

This study tests no drug or treatment. It collects information from people with mild cognitive impairment about their experience with clinical trials. The goal is to learn what makes it hard to join or finish a trial, and whether those barriers differ across demographic groups. The phase is not specified. Details are limited so far.

You may qualify if

  • Confirmed diagnosis of mild cognitive impairment
  • Participant must be 18 years of age or older
  • Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study.

You're excluded if

  • Pregnant or lactating woman
  • Participant is actively receiving study therapy in another
  • Inability to provide written informed consent

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-01-17

View full record on ClinicalTrials.gov

All APOE4 clinical trials